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The binding of folate to Lactobacillus casei dihydrofolate reductase in the presence and absence of NADP+ 
has been studied by lSN NMR, using [5-‘5N]folate. In the presence of NADP+, three separate signals were 
observed for the single lsN atom, in agreement with our earlier evidence from ‘H and 13C NMR for multiple 
conformations of this complex [(1982) Biochemistry 21, 5831-58381. The 15N spectra of the binary enzyme- 
folate complex provide evidence for the first time that this complex also exists in at least two conformational 
states. This is confirmed by the observation of two separate resonances for the 7-proton of bound folate, 
located by two-dimensional exchange spectroscopy. 
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1. INTRODUCTION tion to that seen for methotrexate in the crystal 
[5-71. 
Dihydrofolate reductase is an NADPH-linked 
dehydrogenase which catalyses the reduction of 
folate and dihydrofolate to tetrahydrofolate. It is 
the site of action of the important ‘anti-folate’ 
drugs, including methotrexate and trimethoprim. 
In recent years, a substantial body of structural in- 
formation on complexes of the enzyme with in- 
hibitors has become available from X-ray 
crystallography and NMR spectroscopy (reviews 
[l-4]). By contrast, much less structural informa- 
tion is available on complexes with substrates, 
although stereochemical studies have established 
that the substrate must bind in a different orienta- 
We have previously studied the dihydrofolate 
reductase-folate-NADP+ complex using ‘H, 13C 
and 31P NMR [8] and shown that this complex ex- 
ists in solution in multiple conformations. The 13C 
NMR spectrum of the enzyme complex in which 
the 3-carboxamido of NADP+ was selectively 
enriched with 13C clearly showed signals from 
three conformational states, called forms I, IIa 
and IIb, which are in slow exchange with each 
other on the NMR time scale. Forms IIa and IIb, 
which always appear in constant relative propor- 
tions, are the predominant species at high pH 
whereas form I appears to be the single predomi- 
nant form at low pH. 
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of the coenzyme. We concluded that the dif- 
ferences between the three conformations are 
localised to the region around the nicotinamide 
ring, i.e. close to the bound substrate molecule. 
Most of the available information on this confor- 
mational equilibrium has come from resonances of 
the coenzyme; there is only one carbon-bound pro- 
ton on the pteridine ring of folate, namely H7, and 
in our earlier studies [8] it was not possible to 
locate this resonance in all the states of the com- 
plex. In order to establish how folate is affected by 
this equilibrium and whether the existence of the 
equilibrium depends on the presence of the coen- 
zyme, we have now studied folate binding by “N 
and two-dimensional ‘H NMR. 
2. MATERIALS AND METHODS 
Dihydrofolate reductase was isolated and 
purified from Lactobacillus casei MTX/R [9]. 
[5-“N]Folate was prepared from 2,6-diamino- 
4-pyrimidinol by nitrosation using Na”N02 
and reduction of the 5-nitroso compound with 
Na&04 to yield triamino-4-pyrimidinol. Conden- 
sation with 2-bromo-3,3-dimethoxypropional- 
dehyde, followed by acetylation and hydrolysis of 
the acetal with 88% HCOOH [lo] gave the 2-[5- 
‘5N]acetamidopterin-6-aldehyde. The aldehyde 
was reductively condensed with diethyl p-amino- 
benzoyl-L-glutamate in the presence of borane- 
dimethylamine complex in glacial HOAc solution 
via the general method of Plante [l l] to afford the 
2-acetamido diethyl ester of the labeled folate in 
28% yield. This intermediate was purified by 
chromatography on silica gel with elution by 
CH~OH:CHZCL (1 :9). TLC analysis (silica gel, 
same solvent) showed a single UV-absorbing spot 
at Rf 0.4; mass spectrum (unlabeled run), m/e 539; 
NMR of unlabeled material (CDCl3) 6 1.30 (6H, t, 
ester CH& 2.40 (7H, m, CH&O,-CH2CH2- 
glutamate), 4.20 (4H, m, -OCI-&CH3), 4.75 (3H, 
br s, Cs-CHz, CHCO of glutamate), 6.70 (3H, m, 
3’,5’-ArH, NH), 7.40 (lH, d, NH), 7.75 (2H, d, 
2’,6’-ArH), 8.95 (lH, s, C-7H). 
Subsequent saponification of the diester with 
1 N NaOH in aqueous CHsOH yielded [5-“N]folic 
acid; UV A pH 13 256 nm (log 6 4.40), 286 (4.39), 
366 (3.95), identical with authentic folic acid stan- 
dard. The HPLC spectrum run on a Waters 
Cl*-Radial Pak A cartridge with elution by 
CHsOH : 0.1 N NaH2POb (pH 6.7), 1: 3, showed it 
to be 99% pure and identical to the folic acid stan- 
dard in retention time (with admixture) and peak 
height as measured by absorbance at 3 different 
wavelengths, 254, 284 and 360 nm. 
500 MHz ‘H NMR spectra were obtained by us- 
ing a Bruker AM500 spectrometer. The 0.4 ml 
samples contained 1 .O mM enzyme in 50 mM 
potassium phosphate, 100 mM KCl, 1 mM EDTA, 
1 mM dioxan with 2.0 molar equivalents of folate 
in ‘H20. The two-dimensional exchange experi- 
ment was carried out in the phase-sensitive mode 
using the NOESY (90-t~-90-~,-90-t2-d), se- 
quence and the method of time-proportional phase 
incrementation [121. 1024 data points were record- 
ed in t2 for each of 233 tl values. A spectral width 
of 6410 Hz was used with the carrier frequency at 
the centre of the spectrum and quadrature detec- 
tion in both dimensions. The relaxation delay (d) 
was 0.6 s, and the mixing time (rm) was 100 ms. 
The number of scans per FID (n) was 256 and the 
total accumulation time for the experiment was 
19 h. The data were zero filled to 1024 points in tl 
and processed with a sine bell function in each 
dimension, shifted r/32 in t2 and s/16 in tl. Two- 
dimensional Fourier transformation produced a 
spectrum with a digital resolution in the FZ dimen- 
sion of 12.5 Hz/pt. 
The 15N NMR spectra were obtained from 
3.0 ml samples containing 3.9 mM enzyme in 
50 mM potassium phosphate, 100 mM KC1 in 
2H20, with 0.8 molar equivalent [5-“Nlfolate. 1 .O 
molar equivalent of NADP+ was added later to 
form the ternary complex. The pH* of the sample 
was adjusted between pH* 5.2 and 7.2 using 1 .O M 
solutions of 2HC1 or Na02H. (pH* indicates a 
meter reading uncorrected for the deuterium 
isotope effect on the glass electrode.) 
20 MHz 15N NMR spectra were obtained using 
a Bruker WM200 spectrometer. Quadrature detec- 
tion was used with a spectral width of 5 kHz, a 
pulse interval of 1.64 s, and a 60-90” pulse. Spec- 
tra were recorded for approx. 24 h averaging 
48000 transients. A line broadening of 2-5 Hz was 
applied before transformation. No ‘H decoupling 
was used. 
“NH&l (0.1 M in 0.1 M HCl containing 10% 
2H20) was used as an external reference; its 
resonance appears 295.1 ppm upfield from that of 
free [5-“Nlfolate at pH* 6.3. 
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Fig.1. 20 MHz “N NMR spectra at 278 K of the Fig.2. 20 MHz “N NMR spectra at 278 K of the 
dihydrofolate reductase-[5-15N]folate-NADP+ complex dihydrofolate reductase-[5-“Nlfolate complex at a series 
at a series of pH* values. of pH* values. 
3. RESULTS AND DISCUSSION 
The sample used for the 15N experiments con- 
tained 3.9 mM enzyme and 3.1 mM [5-“Nlfolate. 
Under the conditions of the experiment, the 
binding constant of folate is 2.7 x lo5 M-’ (B. 
Birdsall, unpublished) for the binary complex and 
approx. 20-fold higher in the presence of NADP+ 
[8]. It follows that the concentration of free folate 
will be negligibly small, and any “N resonances 
observed will arise from bound [5-i5N]folate. 
Fig.1 shows the 20 MHz “N spectra of the 
ternary complex, dihydrofolate reductase- 
[5-“Nlfolate-NADP+, at a series of pH* values. In 
the spectrum recorded at pH* 6.3, three signals are 
observed from the single enriched “N atom of 
bound folate. This shows clearly that the complex 
exists in solution in three conformational states. 
As the pH* is changed, the chemical shifts of the 
“N resonances are unaffected, but their relative in- 
tensities change. The pattern of intensity changes is 
closely similar to that reported previously [8] in the 
13C spectra of the same complex formed with 
[carboxamide-‘3C]NADP+. This allows us to 
assign the three 15N signals to the three conforma- 
tional states identified earlier [8]. Conformations 
IIa and IIb, whose ratio is independent of pH*, 
Table 1 
15N chemical shifts of [5-‘5N]folate .bound to 
dihydrofolate reductase= 
Complex 
Enzyme-folate 
Conformation 
I II 
2.7 9.1 
IIa IIb 
Enzyme-folate-NADP+ 2.5 9.9 10.7 
a In ppm downfield from the resonance of free 
[5-15N]folate at pH* 6.3 
108 
Volume 217, number 1 FEBS LETTERS June 1987 
predominate at high pH*, while conformation I 
predominates at low pH*. The “N chemical shifts 
of the three conformations of the complex are 
given in table 1. In all three, the resonance is 
downfield from that of free folate - in the case of 
form IIb, by more than 10 ppm. 
In the lSN spectra of the binary enzyme- 
[5-1SN]folate complex (fig.l), two resonances are 
observed from the single “N at pH* values of 5.6 
or greater. Clearly this complex also exists in more 
than one conformational state. Comparison of the 
lSN chemical shifts (table 1) and the pH* 
dependence of signal intensities suggests that the 
conformations seen in the binary complex 9, 
related to those seen in the ternary complex. 
The “N spectrum of the binary complex at pH* 
5.3 shows a single resonance at 2.7 ppm, close to 
the position of the “N resonance of the low-pH* 
form (form I) of the ternary complex. As the pH* 
is increased, a second resonance appears at 
9.1 ppm in the spectrum of the binary complex, 
and increases in intensity at the expense of the peak 
at 2.7 ppm. The chemical shift of this signal is 
similar to that of the two high-pH* forms (IIa and 
IIb) of the ternary complex. The large difference in 
lSN chemical shift between the low-pH* and high- 
pH* forms (6.4-8.2 ppm) may reflect differences 
in hydrogen-bonding to N5 of folate. Shift dif- 
ferences of this magnitude and direction could be 
produced if in conformation I, N5 is hydrogen- 
bonded (thus having a chemical shift fairly close to 
that in free folate, where it will presumably be 
hydrogen-bonded to water) but in form(s) II it is 
not hydrogen-bonded [13- 151. 
In addition to the similarities between the “N 
spectra of the binary and ternary complexes, there 
are also clear differences. Only a single lSN 
resonance is observed at 9-10 ppm in the spectrum 
of the binary complex, whereas two signals (IIa 
and IIb) are seen in this region for the ternary com- 
plex. This could reflect a genuine difference in the 
conformational equilibria between the binary and 
ternary complexes. Alternatively, it is possible that 
there are three forms of the binary, as of the ter- 
nary, complex, but that the “N chemical shifts 
and/or interconversion rates of forms IIa and IIb 
of the binary complex are such that they are in fast 
exchange on the NMR time scale and so separate 
resonances are not observed. The available data 
and the intrinsic complexity of multisite exchange 
H7 
bound 
P 
ul 
i 
I 5.5 5:0 415 
w2 / mm 
Fig.3. (Top) Low-field region of the 500 MHz ‘H NMR 
spectrum at 278 K of a sample containing dihydrofolate 
reductase and folate in a ratio of 1: 2. The 7-proton 
resonances of free and bound folate are indicated. 
(Bottom) The corresponding region of the 2D exchange 
spectrum, showing the cross-peaks linking the 7-proton 
resonances of free and bound folate. 
systems do not allow us to choose between these 
models. A clear-cut difference between the binary 
and ternary complexes is seen in the apparent pK 
value describing the pH* dependence of the 
relative signal intensities, which is 6.0 in the ter- 
nary complex [8], but >7 in the binary (fig.2). 
These differences may thus be quantitative 
rather than qualitative, and overall the “N spectra 
strongly suggest that the conformations in the 
equilibria are the same or closely similar for the 
binary and ternary complexes. This indicates that 
the presence of the coenzyme is not required for 
this equilibrium to be observed, and focuses atten- 
tion instead on the binding of folate. 
In our previous ‘H studies of the enzyme-folate 
binary complex we have always obtained poorly 
resolved spectra. For example, the histidine 
resonances as well as those of bound and free 
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ligand are all broad in spectra of this complex, 
presumably due to exchange processes. By reduc- 
ing the KC1 concentration from 500 to 100 mM we 
have increased the association constant of folate 
for the enzyme from 2 x lo4 to 2.7 x lo5 M-’ (B. 
Birdsall, unpublished) and perturbed the rate con- 
stants in a favourable manner resulting in the 
sharpening of many signals in the ‘H NMR spec- 
trum (fig.3, top). Under these conditions it was 
then possible to perform a successful two- 
dimensional NOESY/exchange experiment. This 
was carried out on a sample containing 2 molar 
equivalents of folate; the 7-proton resonance of 
free folate can be seen at 4.95 ppm. The cross- 
peaks (off-diagonal peaks) from this resonance 
arise from exchange of folate between the free and 
bound states. As can be seen in fig.3, there are two 
such cross-peaks, indicating that there are two 
bound states for the folate molecule, with 7-proton 
resonances at 4.4 and 5.6 ppm, respectively. Thus 
this experiment provides further evidence for the 
existence of a conformational equilibrium in the 
enzyme-folate binary complex. 
The 1.2 ppm difference between the chemical 
shifts of the folate 7-proton in the two bound 
states uggests aconsiderable difference in the con- 
formation of the bound folate in the two forms. 
Calculations show that the ring current contribu- 
tion to the shift of H7 due to the p-aminobenzoyl 
ring of folate can vary between large positive and 
large negative values depending on the particular 
torsion angles of the bonds connecting the 
pteridine and p-aminobenzoyl rings. The large dif- 
ference in shift of H7 between the two bound con- 
formations could therefore reflect a different 
orientation of the pteridine ring with respect o the 
benzoyl ring in the two forms. If this change in 
orientation of the pteridine ring was accompanied 
by a change in hydrogen-bonding to the pteridine 
NS, it would also, as discussed above, explain the 
“N shift differences. NOE experiments designed 
to test this hypothesis are in progress. 
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